glucose, (beta-d)-isomer has been researched along with Dilatation, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gebhart, GF; Greenwood-van Meerveld, B; Hicks, GA; Johnson, A; McLean, PG; Winchester, WJ | 1 |
| Ness, TJ; Randich, A; Shaffer, AD | 1 |
| DeBerry, J; Ness, TJ; Randich, A; Robbins, MT | 1 |
| Issekutz, AC; Movat, HZ | 1 |
| Abe, T; Endo, Y; Fukudo, S; Hongo, M; Kaku, K; Kobayashi, H; Nakajima, A; Nakajima, T; Nakata, T; Sameshima, K | 1 |
| Hayakawa, T; Katayama, Y; Mishima, T; Ozeki, K; Takagi, Y; Tsuge, H | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Dilatation, Pathologic
| Article | Year |
|---|---|
Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.
Topics: Abdomen; Adult; Constipation; Defecation; Diarrhea; Dilatation, Pathologic; Double-Blind Method; Female; Gastrointestinal Agents; Glucosides; Humans; Male; Middle Aged; Nasopharyngitis; Pyrazoles; Sodium-Glucose Transporter 1; Treatment Outcome | 2018 |
5 other study(ies) available for glucose, (beta-d)-isomer and Dilatation, Pathologic
| Article | Year |
|---|---|
Inhibition of endothelial cell adhesion molecule expression improves colonic hyperalgaesia.
Topics: Animals; Cell Adhesion; Cell Adhesion Molecules; Colitis; Colon; Dilatation, Pathologic; E-Selectin; Endothelial Cells; Gastrointestinal Motility; Humans; Hyperalgesia; Intercellular Adhesion Molecule-1; Leukocytes; Male; Polyethylene Glycols; Purines; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Restraint, Physical; Stress, Psychological; Trinitrobenzenesulfonic Acid; Zymosan | 2009 |
Early-in-life bladder inflammation alters U50,488H but not morphine-induced inhibition of visceromotor responses to urinary bladder distension.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Anesthesia; Animals; Cystitis; Dilatation, Pathologic; Dose-Response Relationship, Drug; Female; Morphine; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reflex; Time Factors; Urinary Bladder; Zymosan | 2013 |
Inflammation-induced enhancement of the visceromotor reflex to urinary bladder distention: modulation by endogenous opioids and the effects of early-in-life experience with bladder inflammation.
Topics: Age Factors; Analgesics, Opioid; Analysis of Variance; Animals; Animals, Newborn; Dilatation, Pathologic; Disease Models, Animal; Electromyography; Female; Inflammation; Muscle Contraction; Naloxone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Sprague-Dawley; Reflex; Urinary Bladder Diseases; Viscera; Zymosan | 2007 |
The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury.
Topics: Alprostadil; Animals; Capillary Permeability; Chemotaxis, Leukocyte; Dilatation, Pathologic; Dinoprostone; Drug Synergism; Female; Hemorrhage; Inflammation; Neutrophils; Prostaglandins E; Rabbits; Skin; Vasodilation; Venules; Zymosan | 1982 |
Ethyl alpha-D-glucoside increases urine volume and causes renal morphologic changes in rats.
Topics: Alcoholic Beverages; Animals; Dilatation, Pathologic; Glucosides; Kidney; Kidney Tubules; Male; Organ Size; Rats; Rats, Wistar; Urine | 2005 |